Stairlifts Market: Foresees Skyrocketing Growth in the Coming Years ulcerative Colitis Market

Ulcerative Colitis Market – Global Industry
Insights, Trends, Outlook, and Opportunity
Analysis, 2018-2026
Ulcerative colitis is the most common type of infammatory bowel disease that afects the colon
(lining of the large intestine) and rectum. The infammation produces tiny sores called ulcers.
These disease can afect people of any age, though prevalence is especially high among people
under 30 years of age. The major symptoms of this disease are diarrhea, belly pain/cramps,
bleeding from the rectum, also other indications are sudden and unexplained weight loss, loss of
appetite, joint pain, eye disease, thickening of the intestinal wall, blood infection (sepsis), kidney
stones and liver disease. The diagnosis of this disease can be carried out by physical
examination using tests such as colonoscopy, endoscopy, biopsy, CT scan and blood test.
If ulcerative colitis persists for over 8 years or longer, it may lead to colon cancer. The people
having mild symptoms of this disease can be cured by over the counter drugs such as Imodium
therapy. However, transcription medicine such as steroid medicines and amino salicylates are
widely used to treat the condition. In severe cases, the patient may need to undergo surgery to
remove the colon, which also helps prevent colon cancer.
Also, some genetically engineered drugs also used to treat ulcerative colitis. These drugs are
made up of certain living organisms that help suppress the infammation, by targeting the
infammatory proteins such as cytokines. Some genetically engineered drugs approved by the
U.S. FDA for treatment of the condition are Adalimumab (Humira), Golimumab (Simponi),
Infiximab (Remicade) and Vedolizumab (Entyvio).
Request Sample Copy of Research Report:
https://www.coherentmarketinsights.com/insight/request-customization/238
High prevalence in developed regions and increasing incidence rate in emerging
economies will play major role in driving growth of the ulcerative colitis market
According to the study of CCFA, industrialized countries have highest incidence rate for
ulcerative colitis. This disease is most prevalent in urban areas than in rural areas, also it can
afect to any age group of people but most cases diagnosed are of the age in between 15t to 35t.
According the stats of World Gastroenterology Organization (WGO), there is rising incidence rate